Correction: Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group

Affiliations

¹ Department of Medicine and The Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC, USA. lorlando@duke.edu.
² Center for Health Services Research in Primary Care, Veterans Affairs Medical Center, Durham, NC, USA.
³ Department of Medicine and The Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC, USA.
⁴ Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
⁵ Department of Medicine and the Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.
⁶ Department of Medicine, University of Maryland, Baltimore, MD, USA.
⁷ Department of Population Health Sciences and Policy and The Center for Health Equity and Community Engaged Research, Icahn School of Medicine at Mount Sinai, New York, New York, NY, USA.
⁸ Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
⁹ Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
¹⁰ National Human Genome Research Institute, Bethesda, MD, USA.
¹¹ Implementation Pathways, LLC, Ann Arbor, MI, USA.
¹² VA Center for Clinical Management Research, Ann Arbor, MI, USA.

Published Erratum

Lori A Orlando et al. Genet Med. 2020 Oct.

. 2020 Oct;22(10):1729.

doi: 10.1038/s41436-020-0910-6.

¹ Department of Medicine and The Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC, USA. lorlando@duke.edu.
² Center for Health Services Research in Primary Care, Veterans Affairs Medical Center, Durham, NC, USA.
³ Department of Medicine and The Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC, USA.
⁴ Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
⁵ Department of Medicine and the Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.
⁶ Department of Medicine, University of Maryland, Baltimore, MD, USA.
⁷ Department of Population Health Sciences and Policy and The Center for Health Equity and Community Engaged Research, Icahn School of Medicine at Mount Sinai, New York, New York, NY, USA.
⁸ Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
⁹ Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
¹⁰ National Human Genome Research Institute, Bethesda, MD, USA.
¹¹ Implementation Pathways, LLC, Ann Arbor, MI, USA.
¹² VA Center for Clinical Management Research, Ann Arbor, MI, USA.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group.
Orlando LA, Sperber NR, Voils C, Nichols M, Myers RA, Wu RR, Rakhra-Burris T, Levy KD, Levy M, Pollin TI, Guan Y, Horowitz CR, Ramos M, Kimmel SE, McDonough CW, Madden EB, Damschroder LJ. Orlando LA, et al. Genet Med. 2018 Jun;20(6):655-663. doi: 10.1038/gim.2017.144. Epub 2017 Sep 14. Genet Med. 2018. PMID: 28914267 Free PMC article.